Company intelligence
ImmuneWatch
The leading software solution for T-cell receptor specificity annotations
Biotechnology Research
Antwerp, BE
7 employees
Founded 2021
2 public signals
About ImmuneWatch
ImmuneWatch supports academics, clinical-stage biotech and pharma companies by using machine learning to identify T-cell receptor targets and analyse immune responses, helping improve (cancer) vaccines and immunotherapies.
Verified activity
Signals from ImmuneWatch
2 published signals
Research & Knowledge
ImmuneWatch published a Cell Reports paper from the University of Antwerp that profiled 394 individuals across five data layers, including gut bacteria, blood immune cell composition, whole blood transcriptomics, and TCR repertoires.
Reported by Sander Wuyts, PhD 🧬
Research & Knowledge
ImmuneWatch DETECT was used inside the TCR data to predict which T cell clones recognised known pathogen epitopes.
Reported by Sander Wuyts, PhD 🧬